RCMI Coordinating Center (RCMI CC)
Home
About
RCMI Coordinating Center
Overview
Sharing Data
Network Graph
Help
History (44)
Subjective social status predicts smoking abstinence among light smokers.
Characterizing Alcohol Use Behaviors among Homeless Men and Women.
Association of baseline characteristics and motivation to change among patients seeking treatment for substance dependence.
ERa upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-?B in breast cancer.
Physiological and behavioral evidence for multiple spectral channels in the larval stomatopod visual system.
See All 44 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Wada, Randal
One or more keywords matched the following items that are connected to
Wada, Randal
Item Type
Name
Concept
Neuroblastoma
Academic Article
PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma.
Grant
N-MYC ONCOGENE REGULATION IN HUMAN NEUROBLASTOMA
Grant
Regulation of the N-myc oncogene in neuroblastoma
Academic Article
Targeting oncogene expression in a childhood cancer.
Academic Article
Retinoic acid induced downregulation of MYCN is not mediated through changes in Sp1/Sp3.
Academic Article
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma.
Academic Article
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.
Academic Article
Maintenance DFMO Increases Survival in High Risk Neuroblastoma.
Academic Article
N-myc oncogene expression in neuroblastoma is driven by Sp1 and Sp3.
Academic Article
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.
Academic Article
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma.
Academic Article
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Search Criteria
Neuroblastoma